Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 23, 2010
Patent Application Number
11599901
Date Filed
November 14, 2006
Patent Primary Examiner
Patent abstract
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
